California State Teachers Retirement System Has $2.70 Million Stake in Oscar Health, Inc. $OSCR

Key Points

• California State Teachers Retirement System increased its Oscar Health stake by 23.3% to 235,443 shares valued at approximately $2.70 million. Institutional investors collectively own 75.70% of the company.
• Analyst sentiment remains mixed, with a consensus “Hold” rating and a $24.00 price target, although Barclays raised its target to $39 and Zacks upgraded the stock to “Strong Buy.”
• Oscar Health reported quarterly EPS of $1.10 versus the $0.40 estimate and revenue of $4.88 billion, up 70.4% year over year. Meanwhile, insiders sold $105.1 million of shares over the past 90 days, including substantial sales by the CEO and CFO under pre-arranged plans.

California State Teachers Retirement System raised its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 23.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 235,443 shares of the company's stock after purchasing an additional 44,443 shares during the quarter. California State Teachers Retirement System owned approximately 0.08% of Oscar Health worth $2,701,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in OSCR. Focus Partners Wealth increased its stake in shares of Oscar Health by 1.4% in the third quarter. Focus Partners Wealth now owns 57,787 shares of the company's stock valued at $1,094,000 after buying an additional 824 shares in the last quarter. Equitable Holdings Inc. grew its holdings in Oscar Health by 7.0% during the 4th quarter. Equitable Holdings Inc. now owns 12,975 shares of the company's stock worth $186,000 after acquiring an additional 850 shares during the last quarter. Captrust Financial Advisors increased its position in Oscar Health by 2.0% in the 4th quarter. Captrust Financial Advisors now owns 45,754 shares of the company's stock valued at $657,000 after acquiring an additional 895 shares in the last quarter. O Shaughnessy Asset Management LLC raised its stake in shares of Oscar Health by 5.6% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 17,774 shares of the company's stock worth $255,000 after acquiring an additional 938 shares during the last quarter. Finally, Binnacle Investments Inc raised its stake in shares of Oscar Health by 28.6% in the third quarter. Binnacle Investments Inc now owns 4,500 shares of the company's stock worth $85,000 after acquiring an additional 1,000 shares during the last quarter. Institutional investors own 75.70% of the company's stock.

Analysts Set New Price Targets

OSCR has been the topic of several research analyst reports. Barclays increased their price target on shares of Oscar Health from $35.00 to $39.00 and gave the company an "overweight" rating in a research note on Thursday. Zacks Research upgraded shares of Oscar Health from a "hold" rating to a "strong-buy" rating in a research report on Monday, July 6th. Robert W. Baird set a $27.00 price objective on Oscar Health in a report on Friday. Jefferies Financial Group upgraded Oscar Health from an "underperform" rating to a "hold" rating and increased their price objective for the company from $10.00 to $16.00 in a research report on Monday, April 20th. Finally, Wall Street Zen raised Oscar Health from a "buy" rating to a "strong-buy" rating in a research note on Sunday, June 14th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Oscar Health currently has a consensus rating of "Hold" and a consensus target price of $24.00.

Insider Buying and Selling

In related news, CFO Richard Scott Blackley sold 31,683 shares of the business's stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $695,125.02. Following the completion of the transaction, the chief financial officer directly owned 1,074,977 shares in the company, valued at approximately $23,584,995.38. The trade was a 2.86% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Mark T. Bertolini sold 624,244 shares of the stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $28.48, for a total value of $17,778,469.12. Following the sale, the chief executive officer directly owned 7,751,570 shares of the company's stock, valued at approximately $220,764,713.60. The trade was a 7.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 3,662,466 shares of company stock valued at $105,145,815. 22.64% of the stock is owned by company insiders.

Oscar Health Trading Down 0.7%

Shares of NYSE OSCR opened at $27.71 on Tuesday. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $33.10. The stock has a market cap of $8.35 billion, a price-to-earnings ratio of 19.79, a P/E/G ratio of 0.75 and a beta of 2.36. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The company's fifty day moving average is $29.03 and its 200-day moving average is $20.48.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $0.40 by $0.70. The business had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a return on equity of 44.96% and a net margin of 3.60%.The firm's revenue was up 70.4% compared to the same quarter last year. During the same quarter last year, the business posted ($0.89) EPS. Equities research analysts predict that Oscar Health, Inc. will post 1.18 EPS for the current year.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source